{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:21:57Z","timestamp":1792790517749,"version":"4.5.0"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2016,11,11]],"date-time":"2016-11-11T00:00:00Z","timestamp":1478822400000},"content-version":"vor","delay-in-days":680,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81301410"],"award-info":[{"award-number":["81301410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471928"],"award-info":[{"award-number":["81471928"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background. \u2003Trichosporon species have emerged as an important non-Candida spp yeast pathogen in immunocompromised patients in recent decades; however, the systemic analysis of Trichosporon epidemiology has seldom been reported.<\/jats:p>\n                  <jats:p>Methods. \u2003We reviewed 185 reported cases of Trichosporon fungemia from 1975 to 2014 in the English-language literature, and the epidemiology and prognostic factors of the included cases are described.<\/jats:p>\n                  <jats:p>Results. \u2003The number of cases reported has increased with time, especially over the past decade. During the 3 decades from 1975 to 2004, the most commonly used antifungal compounds were amphotericin B\/liposomal amphotericin B; however, in recent decades (2005\u20132014), triazoles (especially voriconazole) have become the most widely used agents, significantly improving outcome in the reported cases. Correlation analysis revealed that negative outcome is associated with several prognostic factors, including a history of antimicrobial use, bacterial bloodstream coinfection, prophylactic\/empirical antifungal therapy, Trichosporon beigelii infection, and receiving the antifungal regimen of amphotericin B\/liposomal amphotericin B. In addition, a significantly greater proportion of patients with a positive outcome had fungemia without invasive tissue infection and received a voriconazole regimen or an AmB-triazole combined regimen. Significant positive outcome was also associated with patients who had recovered from neutropenia or after central venous catheter removal.<\/jats:p>\n                  <jats:p>Conclusions. \u2003Voriconazole can be recommended as a first-line antifungal compound to treat Trichosporon fungemia; the immune status of the host plays a crucial role in the outcome of this infection, and the removal of vascular catheters should be considered if feasible.<\/jats:p>","DOI":"10.1093\/ofid\/ofv141","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T20:47:51Z","timestamp":1443300471000},"source":"Crossref","is-referenced-by-count":93,"title":["Epidemiology and Outcome of Trichosporon Fungemia: A Review of 185 Reported Cases From 1975 to 2014"],"prefix":"10.1093","volume":"2","author":[{"given":"Yong","family":"Liao","sequence":"first","affiliation":[{"name":"Department of Dermatology, General Hospital of Beijing Military Command"},{"name":"The Clinical Medical College in the Beijing Military Region of Second Military Medical University of People's Liberation Army"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, General Hospital of Beijing Military Command"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suteng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, General Hospital of Beijing Military Command"},{"name":"The Clinical Medical College in the Beijing Military Region of Second Military Medical University of People's Liberation Army"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[{"name":"Medical Clinic, General Political Department of People's Liberation Army, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Statistics, Second Military Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongya","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, General Hospital of Beijing Military Command"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,9,25]]},"reference":[{"key":"2020081009271278200_OFV141C1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.00003-11","article-title":"Current knowledge of Trichosporon spp. and trichosporonosis","volume":"24","author":"Colombo","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"2020081009271278200_OFV141C2","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1128\/JCM.43.4.1818-1828.2005","article-title":"Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature","volume":"43","author":"Girmenia","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2020081009271278200_OFV141C3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/00365540410017563","article-title":"Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome","volume":"36","author":"Kontoyiannis","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"2020081009271278200_OFV141C4","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1086\/599614","article-title":"Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan","volume":"49","author":"Ruan","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020081009271278200_OFV141C5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1473-3099(10)70218-8","article-title":"Emerging opportunistic yeast infections","volume":"11","author":"Miceli","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2020081009271278200_OFV141C6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jinf.2011.11.002","article-title":"Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer","volume":"64","author":"Chitasombat","year":"2012","journal-title":"J Infect"},{"key":"2020081009271278200_OFV141C7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1099\/jmm.0.45972-0","article-title":"Characterization of Trichosporon species isolated from clinical specimens in Kuwait","volume":"54","author":"Ahmad","year":"2005","journal-title":"J Med Microbiol"},{"key":"2020081009271278200_OFV141C8","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1128\/JCM.02222-08","article-title":"Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov","volume":"47","author":"Taj-Aldeen","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2020081009271278200_OFV141C9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1469-0691.12360","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections","volume":"20","author":"Arendrup","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2020081009271278200_OFV141C10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1586\/eri.11.124","article-title":"Uncommon yeast infections in hematological patients: from diagnosis to treatment","volume":"9","author":"Caira","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2020081009271278200_OFV141C11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1600-0609.2010.01410.x","article-title":"Fatal Trichosporon fungemia in patients with hematologic malignancies","volume":"84","author":"Suzuki","year":"2010","journal-title":"Eur J Haematol"},{"key":"2020081009271278200_OFV141C12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00713937","article-title":"Neotypification of the genus Trichosporon","volume":"61","author":"Gueho","year":"1992","journal-title":"Antonie Van Leeuwenhoek"},{"key":"2020081009271278200_OFV141C13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00713938","article-title":"Contributions to a revision of the genus Trichosporon","volume":"61","author":"Gueho","year":"1992","journal-title":"Antonie van Leeuwenhoek"},{"key":"2020081009271278200_OFV141C14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s005200050221","article-title":"Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol","volume":"7","author":"Krcmery","year":"1999","journal-title":"Support Care Cancer"},{"key":"2020081009271278200_OFV141C15","doi-asserted-by":"crossref","first-page":"e1004982","DOI":"10.1371\/journal.ppat.1004982","article-title":"On and under the skin: emerging basidiomycetous yeast infections caused by Trichosporon species","volume":"11","author":"Marine","year":"2015","journal-title":"PLoS Pathog"},{"key":"2020081009271278200_OFV141C16","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1128\/JCM.01614-08","article-title":"Bloodstream infections due to Trichosporon spp. species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing","volume":"47","author":"Chagas-Neto","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2020081009271278200_OFV141C17","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1128\/JCM.33.5.1368-1370.1995","article-title":"Taxonomic position of deep-seated, mucosa-associated, and superficial isolates of Trichosporon cutaneum from trichosporonosis patients","volume":"33","author":"Sugita","year":"1995","journal-title":"J Clin Microbiol"},{"key":"2020081009271278200_OFV141C18","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1128\/JCM.37.6.1985-1993.1999","article-title":"Identification of medically relevant Trichosporon species based on sequences of internal transcribed spacer regions and construction of a database for Trichosporon identification","volume":"37","author":"Sugita","year":"1999","journal-title":"J Clin Microbiol"},{"key":"2020081009271278200_OFV141C19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1439-0507.1994.tb00277.x","article-title":"Trichosporon on humans: a practical account","volume":"37","author":"Gueho","year":"1994","journal-title":"Mycoses"},{"key":"2020081009271278200_OFV141C20","doi-asserted-by":"crossref","first-page":"732573","DOI":"10.1155\/2015\/732573","article-title":"Development of a loop-mediated isothermal amplification assay for rapid detection of Trichosporon asahii in experimental and clinical samples","volume":"2015","author":"Zhou","year":"2015","journal-title":"BioMed Res Int"},{"key":"2020081009271278200_OFV141C21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1439-0507.2005.01134.x","article-title":"Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors","volume":"48","author":"Boo","year":"2005","journal-title":"Mycoses"},{"key":"2020081009271278200_OFV141C22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s10096-003-0890-x","article-title":"Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality","volume":"22","author":"Alonso-Valle","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020081009271278200_OFV141C23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020081009271278200_OFV141C24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0732-8893(01)00215-2","article-title":"Trichosporon species infection in bone marrow transplanted patients","volume":"39","author":"Moretti-Branchini","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2020081009271278200_OFV141C25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1086\/500323","article-title":"Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin","volume":"42","author":"Matsue","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2020081009271278200_OFV141C26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s15010-007-6278-6","article-title":"Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin","volume":"36","author":"Bayramoglu","year":"2008","journal-title":"Infection"},{"key":"2020081009271278200_OFV141C27","first-page":"2632","article-title":"Breakthrough trichosporonosis in patients receiving echinocandins: case report and literature review","volume":"125","author":"Liao","year":"2012","journal-title":"Chin Med J"},{"key":"2020081009271278200_OFV141C28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijid.2008.04.009","article-title":"Fungemia in non-HIV-infected patients: a five-year review","volume":"13","author":"Anunnatsiri","year":"2009","journal-title":"Int J Infect Dis"},{"key":"2020081009271278200_OFV141C29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1471-2334-13-247","article-title":"Clinical characteristics and risk factors of non-Candida fungaemia","volume":"13","author":"Yamamoto","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2020081009271278200_OFV141C30","first-page":"127","article-title":"Trichosporon beigelii fungemia in patients with acute leukemia: report of three cases","volume":"94","author":"Hung","year":"1995","journal-title":"J Formos Med Assoc"},{"key":"2020081009271278200_OFV141C31","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1128\/AAC.03817-14","article-title":"In vitro activities of antifungal combinations against biofilms and planktonic forms of clinical Trichosporon asahii isolates","volume":"58","author":"Liao","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2020081009271278200_OFV141C32","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1128\/AAC.00556-06","article-title":"Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance","volume":"50","author":"Di Bonaventura","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2020081009271278200_OFV141C33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jhin.2005.02.009","article-title":"Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality","volume":"61","author":"Weinberger","year":"2005","journal-title":"J Hosp Infect"},{"key":"2020081009271278200_OFV141C34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jac\/dks347","article-title":"Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections","volume":"68","author":"Garnacho-Montero","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2020081009271278200_OFV141C35","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10096-008-0546-y","article-title":"A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia","volume":"27","author":"Velasco","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020081009271278200_OFV141C36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/00365540510026814","article-title":"Improving survival of patients with candidaemia: analysis of prognostic factors from a long-term, nationwide study in Iceland","volume":"37","author":"Asmundsdottir","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"2020081009271278200_OFV141C37","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jinf.2008.12.008","article-title":"Candidemia in cancer patients: impact of early removal of non-tunneled central venous catheters on outcome","volume":"58","author":"Liu","year":"2009","journal-title":"J Infect"},{"key":"2020081009271278200_OFV141C38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/653935","article-title":"Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials","volume":"51","author":"Nucci","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2020081009271278200_OFV141C39","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/338714","article-title":"Should vascular catheters be removed from all patients with candidemia? An evidence-based review","volume":"34","author":"Nucci","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2020081009271278200_OFV141C40","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1469-0691.2007.01758.x","article-title":"Impact of early central venous catheter removal on outcome in patients with candidaemia","volume":"13","author":"Rodriguez","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"2020081009271278200_OFV141C41","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/mmy\/myv006","article-title":"Efficacy of ethanol against Trichosporon asahii biofilm in vitro","volume":"53","author":"Liao","year":"2015","journal-title":"Med Mycol"},{"key":"2020081009271278200_OFV141C42","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/clinids\/20.4.913","article-title":"Bloodstream infection due to Trichosporon beigelii in a burn patient: case report and review of therapy","volume":"20","author":"Hajjeh","year":"1995","journal-title":"Clin Infect Dis"},{"key":"2020081009271278200_OFV141C43","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1128\/JCM.28.7.1616-1622.1990","article-title":"Trichosporon beigelii, an emerging pathogen resistant to amphotericin B","volume":"28","author":"Walsh","year":"1990","journal-title":"J Clin Microbiol"},{"key":"2020081009271278200_OFV141C44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1348-0421.2002.tb02663.x","article-title":"Antifungal pharmacodynamic characteristics of amphotericin B against Trichosporon asahii, using time-kill methodology","volume":"46","author":"Toriumi","year":"2002","journal-title":"Microbiol Immunol"},{"key":"2020081009271278200_OFV141C45","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1128\/JCM.41.11.5317-5320.2003","article-title":"Disseminated trichosporonosis caused by Trichosporon loubieri","volume":"41","author":"Marty","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2020081009271278200_OFV141C46","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1128\/AAC.38.11.2541","article-title":"Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis","volume":"38","author":"Anaissie","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"2020081009271278200_OFV141C47","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/infdis\/166.1.121","article-title":"Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis","volume":"166","author":"Walsh","year":"1992","journal-title":"J Infect Dis"},{"key":"2020081009271278200_OFV141C48","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/clind\/15.5.781","article-title":"Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review","volume":"15","author":"Anaissie","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2020081009271278200_OFV141C49","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1086\/432060","article-title":"Emerging fungal diseases","volume":"41","author":"Nucci","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2020081009271278200_OFV141C50","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s10096-002-0841-y","article-title":"Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia","volume":"21","author":"Fournier","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020081009271278200_OFV141C51","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/AAC.00045-06","article-title":"Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis","volume":"50","author":"Serena","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2020081009271278200_OFV141C52","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1399-3062.2011.00670.x","article-title":"Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B","volume":"14","author":"Hosokawa","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"2020081009271278200_OFV141C53","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3109\/13693786.2010.525758","article-title":"Fatal invasive trichosporonosis due to Trichosporon loubieri in a patient with T-lymphoblastic lymphoma","volume":"49","author":"Gabriel","year":"2011","journal-title":"Med Mycol"},{"key":"2020081009271278200_OFV141C54","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1128\/AAC.46.4.1144-1146.2002","article-title":"In vitro antifungal susceptibilities of Trichosporon species","volume":"46","author":"Paphitou","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2020081009271278200_OFV141C55","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1128\/JCM.41.2.911.2003","article-title":"Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole","volume":"41","author":"Falk","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2020081009271278200_OFV141C56","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ijantimicag.2010.01.013","article-title":"In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii","volume":"35","author":"Li","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"2020081009271278200_OFV141C57","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dki218","article-title":"Changing patterns and trends in systemic fungal infections","volume":"56","author":"Richardson","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"2020081009271278200_OFV141C58","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1128\/JCM.39.12.4420-4425.2001","article-title":"Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units","volume":"39","author":"Wolf","year":"2001","journal-title":"J Clin Microbiol"},{"key":"2020081009271278200_OFV141C59","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF01739918","article-title":"Successful treatment of a Trichosporon beigelii septicemia in a granulocytopenic patient with amphotericin B and granulocyte colony-stimulating factor","volume":"22","author":"Grauer","year":"1994","journal-title":"Infection"},{"key":"2020081009271278200_OFV141C60","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00005792-198607000-00005","article-title":"Trichosporonosis in patients with neoplastic disease","volume":"65","author":"Walsh","year":"1986","journal-title":"Medicine"},{"key":"2020081009271278200_OFV141C61","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/sj.bmt.1702231","article-title":"Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts","volume":"25","author":"Erer","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"2020081009271278200_OFV141C62","doi-asserted-by":"crossref","first-page":"O50","DOI":"10.1111\/1469-0691.12312","article-title":"A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies","volume":"20","author":"Gamaletsou","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2020081009271278200_OFV141C63","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF01974540","article-title":"Disseminated Trichosporon beigelii infection in patients with malignant diseases: immunohistochemical study and review","volume":"13","author":"Tashiro","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020081009271278200_OFV141C64","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/infdis\/170.6.1557","article-title":"Response of human polymorphonuclear leukocytes and monocytes to Trichosporon beigelii: host defense against an emerging opportunistic pathogen","volume":"170","author":"Lyman","year":"1994","journal-title":"J Infect Dis"},{"key":"2020081009271278200_OFV141C65","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1439-0507.2011.02040.x","article-title":"Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy","volume":"54","author":"Ruhnke","year":"2011","journal-title":"Mycoses"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/2\/4\/ofv141\/33602528\/ofv141.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/2\/4\/ofv141\/33602528\/ofv141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T09:38:50Z","timestamp":1597052330000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofv141\/2460334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofv141","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725935069.793538215","asserted-by":"object"}]},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015]]},"published":{"date-parts":[[2015]]},"article-number":"ofv141"}}